Hopman Mark

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Beta Bionics, Inc.Chief Commercial OfficerOpen-market sell$664,55035,994 sharesSep 18, 2026Beta Bionics, Inc.Chief Commercial Officer$664,550Sell · Sep 18Open-market sell35,994Sep 18, 2026
Beta Bionics, Inc.Chief Commercial OfficerOpen-market sell$619,64030,779 sharesSep 17, 2026Beta Bionics, Inc.Chief Commercial Officer$619,640Sell · Sep 17Open-market sell30,779Sep 17, 2026
Beta Bionics, Inc.Chief Commercial OfficerOpen-market sell$12,028775 sharesSep 15, 2026Beta Bionics, Inc.Chief Commercial Officer$12,028Sell · Sep 15Open-market sell775Sep 15, 2026
Beta Bionics, Inc.Chief Commercial OfficerOpen-market sell$680,72336,870 sharesSep 10, 2026Beta Bionics, Inc.Chief Commercial Officer$680,723Sell · Sep 10Open-market sell36,870Sep 10, 2026
Beta Bionics, Inc.Chief Commercial OfficerOpen-market sell$101,8155,327 sharesSep 3, 2026Beta Bionics, Inc.Chief Commercial Officer$101,815Sell · Sep 3Open-market sell5,327Sep 3, 2026